Los Angeles Capital Management LLC Precigen, Inc. Transaction History

Los Angeles Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$0.96 - $1.4 $210,664 - $307,218	-219,442 Reduced 50.71%	213,294 $245,000
Q1 2023 May 04, 2023	SELL	$0.88 - $2.19 $11,582 - $28,824	-13,162 Reduced 2.95%	432,736 $458,000
Q4 2022 Feb 06, 2023	SELL	$1.27 - $2.26 $65,140 - $115,919	-51,292 Reduced 10.32%	445,898 $677,000
Q3 2022 Nov 02, 2022	SELL	$1.41 - $2.79 $162,870 - $322,275	-115,511 Reduced 18.85%	497,190 $1.05 Million
Q2 2022 Aug 05, 2022	SELL	$1.15 - $2.53 $18,630 - $40,986	-16,200 Reduced 2.58%	612,701 $821,000
Q1 2022 May 06, 2022	SELL	$1.91 - $3.98 $95,826 - $199,680	-50,171 Reduced 7.39%	628,901 $1.33 Million
Q4 2021 Feb 03, 2022	BUY	$3.53 - $5.5 $561,217 - $874,417	158,985 Added 30.57%	679,072 $2.52 Million
Q3 2021 Nov 08, 2021	BUY	$4.99 - $6.55 $2.6 Million - $3.41 Million	520,087 New	520,087 $2.6 Million

141

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $231M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.